Using multiomic integration to improve blood biomarkers of major depressive disorder: a case-control study

dc.contributor.author Mokhtari, Amazigh
dc.contributor.author Decraene, Charles
dc.contributor.author Ibrahim, El
dc.contributor.author Marie-Claire, Cynthia
dc.contributor.author Etain, Bruno
dc.contributor.author Belzeaux, Raoul
dc.contributor.author Lutz, Pierre-Eric
dc.contributor.author Charbonnier, Guillaume
dc.contributor.author Loriod, Béatrice
dc.contributor.author Yalcin, Ipek
dc.contributor.author Delahaye-Duriez, Andrée
dc.contributor.author Cohen, David
dc.contributor.author Gloaguen, Arnaud
dc.contributor.author Derouin, Margot
dc.contributor.author Barrot, Claire-Cécile
dc.contributor.author Vachon, Hortense
dc.date.accessioned 2025-12-31T14:27:34Z
dc.date.available 2025-12-31T14:27:34Z
dc.date.issued 2025-03-01
dc.description Major depressive disorder (MDD) is a leading cause of disability, with a twofold increase in prevalence in women compared to men. Over the last few years, identifying molecular biomarkers of MDD has proven challenging, reflecting interactions among multiple environmental and genetic factors. Recently, epigenetic processes have been proposed as mediators of such interactions, with the potential for biomarker development.We characterised gene expression and two mechanisms of epigenomic regulation, DNA methylation (DNAm) and microRNAs (miRNAs), in blood samples from a cohort of individuals with MDD and healthy controls (n = 169). Case-control comparisons were conducted for each omic layer. We also defined gene coexpression networks, followed by step-by-step annotations across omic layers. Third, we implemented an advanced multiomic integration strategy, with covariate correction and feature selection embedded in a cross-validation procedure. Performance of MDD prediction was systematically compared across 6 methods for dimensionality reduction, and for every combination of 1, 2 or 3 types of molecular data. Feature stability was further assessed by bootstrapping.Results showed that molecular and coexpression changes associated with MDD were highly sex-specific and that the performance of MDD prediction was greater when the female and male cohorts were analysed separately, rather than combined. Importantly, they also demonstrated that performance progressively increased with the number of molecular datasets considered.Informational gain from multiomic integration had already been documented in other medical fields. Our results pave the way toward similar advances in molecular psychiatry, and have practical implications for developing clinically useful MDD biomarkers.This work was supported by the Centre National de la Recherche Scientifique (contract UPR3212), the University of Strasbourg, the Université Sorbonne Paris Nord, the Université Paris Cité, the Fondation de France (FdF N° Engt:00081244 and 00148126; ECI, IY, RB, PEL), the French National Research Agency (ANR-18-CE37-0002, BE, CMC, ADD, PEL, ECI; ANR-18-CE17-0009, ADD; ANR-19-CE37-0010, PEL; ANR-21-RHUS-009, ADD, BE, CMC, CCB; ANR-22-PESN-0013, ADD), the Fondation pour la Recherche sur le Cerveau (FRC 2019, PEL), Fondation de France (2018, BE, CMC, ADD) and American Foundation for Suicide Prevention (AFSP YIG-1-102-19; PEL).
dc.description.spage 105569
dc.description.volume 113
dc.identifier.doi 10.1016/j.ebiom.2025.105569
dc.identifier.issn 2352-3964
dc.identifier.pmc PMC11848217
dc.identifier.pmid 39914267
dc.identifier.uri https://ror.circle-u.eu/handle/123456789/1715319
dc.openaire.affiliation Université Paris Cité
dc.openaire.affiliation Université Paris Cité
dc.openaire.affiliation Université Paris Cité
dc.openaire.collaboration 3
dc.publisher Elsevier BV
dc.rights OPEN
dc.rights.license c_abf2
dc.source eBioMedicine
dc.subject Articles
dc.subject Multiomic integration
dc.subject 610
dc.subject Sex differences
dc.subject [SDV]Life Sciences [q-bio]
dc.subject Depression
dc.subject microRNA
dc.subject Transcriptomic
dc.subject DNA methylation
dc.subject 570
dc.subject [SDV] Life Sciences [q-bio]
dc.title Using multiomic integration to improve blood biomarkers of major depressive disorder: a case-control study
dc.type publication

Files

Collections